Odyssey Pharms Company Profile
What is the competitive landscape for ODYSSEY PHARMS
ODYSSEY PHARMS has seven approved drugs.
Drugs and US Patents for Odyssey Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088482-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 088440-001 | May 29, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 089095-001 | Dec 19, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | NYSTATIN | nystatin | TABLET;VAGINAL | 062615-001 | Oct 17, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088483-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 089096-001 | Dec 19, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 088441-001 | May 29, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

